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Abstract
Background: Beta-catenin is part of a protein complex associated with adherens junctions. When allowed to
accumulate to sufficient levels in its dephosphorylated form, beta-catenin serves as a transcriptional co-activator
associated with a number of signaling pathways, including steroid hormone signaling pathways.
Methods: To investigate the role of beta-catenin in progesterone (P4) signaling and female reproductive
physiology, conditional ablation of Ctnnb1 from the endometrial mesenchymal (i.e. stromal and myometrial), but
not epithelial, compartment was accomplished using the Amhr2-Cre mice. Experiments were conducted to assess
the ability of mutant female mice to undergo pregnancy and pseudopregnancy by or through oil-induced
decidualization. The ability of uteri from mutant female mice to respond to estrogen (E2) and P4 was also
determined.
Results: Conditional deletion of Ctnnb1 from the mesenchymal compartment of the uterus resulted in infertility
stemming, in part, from complete failure of the uterus to decidualize. E2-stimulated epithelial cell mitosis and
edematization were not altered in mutant uteri indicating that the mesenchyme is capable of responding to E2.
However, exposure of ovariectomized mutant female mice to a combined E2 and P4 hormone regimen consistent
with early pregnancy revealed that mesenchymal beta-catenin is essential for indirectly opposing E2-induced
epithelial proliferation by P4 and in some mice resulted in development of endometrial metaplasia. Lastly, beta-
catenin is also required for the induced expression of genes that are known to play a fundamental role in
decidualization such as Ihh, Ptch1, Gli1 and Muc1
Conclusions: Three salient points derive from these studies. First, the findings demonstrate a mechanistic linkage
between the P4 and beta-catenin signaling pathways. Second, they highlight an under appreciated role for the
mesenchymal compartment in indirectly mediating P4 signaling to the epithelium, a process that intimately
involves mesenchymal beta-catenin. Third, the technical feasibility of deleting genes in the mesenchymal
compartment of the uterus in an effort to understand decidualization and post-natal interactions with the overlying
epithelium has been demonstrated. It is concluded that beta-catenin plays an integral role in selective P4-directed
epithelial-mesenchymal communication in both the estrous cycling and gravid uterus.
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The stromal/mesenchymal compartment of the endo-
metrium performs a variety of tasks important for uter-
ine physiology, including relaying specific aspects of
steroid hormone signaling to the overlying epithelium.
An example of such mesenchymal-to-epithelial signaling
occurs in response to estradiol (E2) binding to and acti-
vating estrogen receptor (ESR1), inducing the expression
of stromal-derived growth factors that stimulate epithe-
lial cell cycle progression, hypertrophy, and initiating
secretory functions (reviewed in [1]). In invasively
implanting species, the stroma also undergoes deciduali-
zation during early pregnancy following embryo appos-
ition and attachment to the uterine luminal epithelium,
a process inherently regulated by progesterone (P4) fol-
lowing E2 priming. Here, stromal cells terminally differ-
entiate and contribute to pregnancy by performing
placenta-like functions until such time that the embryo
develops its own nutrient and gas exchange apparatus,
the placenta [2]. Stromal decidualization is regulated, in
part, by cues derived from the epithelium such as Indian
hedgehog.
It is thought that ESR1 mediates E2-initiated signaling in
the uterus. However, it is generally understood that E2-
initiated transcriptional and physiological changes occur in
two phases [3]. The first occurs within 2–6h o u r s ,a n dt h e
second takes place between 24–72 hours. Although many
E2-initiated transcriptional events require binding of ESR1
to estrogen response elements (ERE), many other genes
are regulated in an ER-dependent, but ERE-independent
fashion [4]. This suggests that ESR1 interacts with other
transcriptional modulators that in turn interact with DNA
to regulate gene expression at promoter sites distinct from
EREs. Within the uterine epithelium, one such ESR1 inter-
acting molecule is the transcriptional co-activator β-cate-
nin [5,6]. The late transcriptional response to E2 is thought
to be mediated, in part, by the ESR1:β-catenin interaction.
Equally complex signaling mechanisms likely coordinate P4
responses, but such pathways are less clearly understood.
β-catenin is best known for its central role in the canon-
ical wingless-type MMTV integration site family member
(Wnt) signaling pathways and β-catenin is essential for de-
velopment, transcription, cell adhesion and tumorigenesis
[7]. In the absence of Wnt signaling, β-catenin is found in
the cytoplasm either as a component that binds cadherins
to α-catenin and the cytoskeleton at adherens junctions or
in a complex with adenomatous polyposis coli (APC), axin,
and glycogen synthase kinase 3β (GSK-3β), wherein it is
phosphorylated and subject to ubiquitination and proteaso-
mal degradation. Activation of frizzled receptors by Wnt
ligands disrupts the APC complex and inhibits GSK-3β
activity causing an accumulation of unphosphorylated
(i.e., activated) β-catenin, which promotes its nuclear
localization and subsequent regulation of target gene
expression [8]. β-catenin is therefore uniquely situated
at a bottleneck in the Wnt signaling pathway.
Much of the focus of steroid hormone signaling stud-
ies in the uterus has been directed at the epithelial com-
partment. In the present study, the function of β-catenin
in the stromal compartment was investigated in the
contexts of steroid hormone action and stromal cell
decidualization. Our findings reveal that conditional in-
activation of β-catenin in endometrial stroma results in
disrupted progesterone signaling and complete loss of
stromal cell decidua-lization, indicating that steroid-
dependent and β-catenin signaling pathways intersect to
regulate postnatal uterine functions.
Methods
Animals
Animal protocols were approved by either the
Massachusetts General Hospital or the Washington
State University Institutional Care and Use Committee.
For histology, mature (6–8 weeks old) ICR female mice
were placed with intact ICR males of proven breeding
capacity or with vasectomized ICR males. Female mice
were considered day of pregnancy (DOP) or day of
pseudopregnancy (DOPP) 0.5 upon observation of a va-
ginal seminal plug. Whole implantation sites (pregnancy)
or mechanically decidualized uterine tissue (pseudopreg-
nancy) were collected on days 4.5, 6.5 and 7.5 and
prepared for RNA isolation or paraffin sectioning as
described below. Decidualization was induced in pseu-
dopregnant female mice by infusing 10 μl of sesame oil
into the uterine lumen on DOPP 4.
The utility of the anti-Müllerian hormone type II
receptor (Amhr2) promoter to drive Cre recombinase
expression in mice during uterine decidualization was
first established by crossing Amhr2
Cre transgenic mice
(Amhr2
tm3(cre)Bhr/+), kindly provided by Dr. Richard
Behringer or purchased from the Mutant Mouse
Regional Resource Center, with Rosa-EYFP reporter mice
containing a yellow fluorescent protein gene down-
stream of a loxP-flanked stop sequence (Gt(ROSA)
26Sor
tm1(EYFP)Cos) [9]. To study β-catenin function in
endometrial stromal tissue Amhr2
Cre mice were mated
with mice harboring a Ctnnb1 gene with exons 2–6
flanked by loxP sites (Ctnnb1
tm2Kem/KnwJ ; The Jackson
Laboratories, Bar Harbor, ME; [10]). Double transgenic
Amhr2
Cre/+;Ctnnb1
flox/+ offspring derived from this first
mating were then crossed to generate conditional mu-
tant (Amhr2
Cre/+;Ctnnb1
d/d) and control (Amhr2
Cre/+;
Ctnnb1
d/+ or Ctnnb1
flox/flox) littermates. Attempts were
made to induce decidualization using both natural (preg-
nancy) and artificial (intrauterine sesame oil injections
during pseudopregnancy; [11]) means in control mice
expressing β-catenin in the stromal compartment, as
well as in mutant Amhr2
Cre/+;Ctnnb1
d/d mice. To study
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rial tissue from control and conditionally mutant female
mice, ovariectomies were performed between three and
five weeks of age. One week later, female mice were trea-
ted subcutaneously with steroid hormones as indicated
in the legend of each figure. Tissues were collected at
specified times, prepared for paraffin sectioning and
analyzed for proliferation (BrdU labeling) and/or mitosis
(phospho-histone H3 expression) as described below.
Messenger RNA and protein expression analyses
Total RNA was extracted from individual samples and
reverse transcribed (Superscript II RT; Invitrogen,
Carlsbad, CA) with oligo-dT primers following DNase I
treatment to eliminate genomic DNA contamination.
Standard RT-PCR was then performed for genes of
interest using primer sets listed in Table 1. β-actin
mRNA was used as an internal control and a mock RT
was also included as a template to confirm the absence
of genomic DNA contamination. Quantitative RT-PCR
analysis of Gli1, Ptch1, Ihh, Muc1and β-actin mRNA
levels, was performed using a Cepheid Smart Cycler II
with primers specific for each gene (Table 1) and Q
SYBR Green Supermix (Bio-Rad). Relative quantification
of mRNA levels was determined in which ratios for each
gene was established using β-actin as a reference gene.
For immunohistochemical and immunofluorescent
analyses, whole implantation sites and mechanically
decidualized uterine tissues were prepared from paraffin
or frozen sections as previously described [11,12]. Fro-
zen uterine tissue sections from Rosa-EYFP transgenic
mice were counterstained with DAPI and viewed directly
using fluorescence microscopy. Sections processed for
immunofluorescence were incubated with anti-total
β-catenin antibodies at a dilution of 1:200 (Abcam) fol-
lowed by incubation with an Alexafluor 546 conjugated
secondary antibody (Invitrogen) and mounting medium
containing DAPI.
For immunohistochemical detection of the active form
of β-catenin, phospho-histone H3, ESR1 and progester-
one receptor (PGR), paraffin embedded uterine sections
were prepared as described elsewhere [11]. Sections were
incubated with primary antibody diluted [(1:100 for anti-
active β-catenin (Millipore), 1:2000 for anti-phospho-his-
tone H3 (Upstate Biotechnologies), 1:300 for anti-ESR1
(Santa Cruz) and 1:300 for anti-PGR (Dako)], then incu-
bated with biotinylated secondary antibody (1:500; Santa
Cruz Biotechnologies) and horseradish peroxidase-conju-
gated streptavidin (Vector Laboratories; Burlingame, CA).
Sections were exposed to 3,3’-diaminobenzidine (DAB)
substrate, counterstained with hematoxylin, dehydrated,
and mounted for light microscopy. The mean ratio of mi-
totic epithelial cells in endometrial tissue sections was
established by counting the number of phospho-histone
H3-positive cells and dividing by the total number of cells
(mean of three tissue sections obtained from three differ-
ent regions of the uterus) following standard immunohis-
tochemical detection. β-catenin expression was also
assessed by immunofluorescence in primary human endo-
metrial stromal cells (kindly provided by Dr. Bo Rueda,
Massachusetts General Hospital) induced to undergo
decidualization in vitro by provision of 100 μM cAMP, 36
nM 17β-estradiol benzoate, and 1 μMP 4 for 12 days.
BrdU labeling and analysis of cellular proliferation
To assess cell proliferation in the individual epithelial and
stromal compartments, control and mutant female mice
were first ovariectomized at three to five weeks of age and
allowed to clear endogenous ovarian-derived sex steroids
for at least one week. Female mice then received E2
(100 ng s.c. in 100 μl sesame oil) on two consecutive days
to prime the uterus and six days later began one of the fol-
lowing steroid hormone treatments. For epithelial cell
proliferation, female mice received a single s.c. injection of
E2 (50 ng in 50 μlo fs e s a m eo i l )( n = 5c o n t r o l s ,n = 3
mutants). For stromal cell proliferation, female mice were
injected with P4 (1 mg s.c. in 100 μl sesame oil) for three
consecutive days and the following day with E2+P 4 (50 ng
and 1 mg respectively in 100 μl sesame oil)] (n=8 controls
and mutants). Then 16 hrs after the final steroid hormone
injection, female mice were treated with 50 mg/kg body
weight 5-bromo-2’-deoxyuridine (BrdU; i.p. in 250 μls a -
line) for 2 hours prior to euthanasia and uterine dissec-
tion. Tissues were prepared for paraffin embedding and
Table 1 PCR primers
Murine Gene Primer sequence Annealing temperature Cycles
Pgr 5’ATGGTCCTTGGAGGTCGTAA3’ 5’CACCATCAGGCTCATCC3’ 60 34
Esr1 5’CCAAAGCCTCGGGAATG3’ 5CTTTCTCGTTACTGCTGG3’ 56 33
Esr2 5’GGGCCTGTTCGCCAGACTGC3’ 5’CAGGGATTTTCTTGGC3’ 56 33
Ihh 5’CGTGCATTGCTCTGTCAAGT3’ 5’CTCGATGACCTGGAAAGCTC3’ 56 37
Pct1 5’CCTCCTTTACGGTGGACAAA 3’ 5’ GCCACATCAAGAGGTTTGGT 3’ 56 40
Gli1 5’CCTGGTGGCTTTCATCAACT3’ 5’GTGGTACACAGGGCTGGAGT3’ 56 38
β-actin 5’GATGACGATATCGCTGCGCTG3’ 5’GTACGACCAGAGGCATACAGG3’ 60 26
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each uterus were used to assess BrdU incorporation
immunohistochemically using a BrdU staining kit (Invi-
trogen Corporation, Camarillo, CA) per manufacturer’s
instructions. The mean percentages of BrdU positive
cells in the luminal epithelium (LE) and stroma were
calculated by establishing a ratio of BrdU positive cells
divided by the total number of cells within the luminal
epithelium or subluminal stromal compartment.
Experimental replication and statistical analysis
Each experiment was independently replicated a mini-
mum of three times with different mice in each experi-
ment. Data in graphs represent the mean±SEM from
replicated experiments. Assignment of mice to each
experiment was made randomly. Raw data were analyzed
with GraphPad PRISM software (version 4.0) for simple
comparisons. Mean values were considered significantly
different when p<0.05.
Results
β-catenin expression during uterine receptivity and
stromal decidualization
Our initial investigation showed that total β-catenin pro-
tein was observed throughout the implantation site on
day of pregnancy (DOP) 7.5 (Figure 1A). The honey-
comb expression pattern showed that β-catenin localized
to the plasma membranes of decidualized stromal cells
of both the antimesometrial and mesometrial compart-
ments, consistent with its role in maintaining adherens
function [13,14]. Similarly, expression of β-catenin was
observed in primary human decidual cells (Figure 1B),
as well as decidual cells of mechanically-induced pseu-
dopregnant female mice on day of pseudopregnancy
(DOPP) 6.5 (Figure 1C). We also analyzed whether
localization of β-catenin to the nuclei of stromal cells
changed with decidualization and observed that the
active, dephosphorylated form of β-catenin was detected
at the initial stages of decidualization on DOP 4.5 in
both epithelial and stromal cells (Figure 1E). While the
active form of β-catenin became localized to the mem-
branes, cytoplasm and nuclei of epithelial cells on DOP
4.5, active β-catenin localized predominantly to the nu-
clei of stromal cells undergoing decidualization. This
finding supports endocrine-dependent transcriptional
and cell cycle regulatory roles for β-catenin in the stro-
mal compartment as has been previously suggested
based on the use of an ovariectomized rat model supple-
mented with steroid hormones [15]. By DOP 7.5, stain-
ing for active β-catenin was diminished in terminally
differentiated decidual cells (Figure 1G). A similar ex-
pression profile was observed for active β-catenin on
corresponding days of pseudopregnancy where decidua-
lization was initiated by artificial means (data not
shown). β-catenin was not detected in control sections
where primary antibody was omitted (Figure 1D, F, H).
myo myo
deciduoma deciduoma
A B C D
E F G H
Figure 1 Immunofluorescent detection of β-catenin during uterine decidualization. Shown are representative images of total β-catenin
immunofluorescent staining in transverse sections of implantation sites obtained on day of pregnancy (DOP) 7.5 (A), decidualized primary human
endometrial stromal cells (B) and transverse sections of decidualized uterine tissue from day of pseudopregnancy (DOPP) 6.5 (C, D). Total β-
catenin is expressed primarily at the cell surface of decidual stromal cells through the antimesometrial (A, 400X) and mesometrial (data not
shown) poles on DOP 7.5, as well as in primary human endometrial stromal cells induced to undergo decidualization (B, 1000X). On DOPP 6.5 β-
catenin is abundantly expressed in the stromal deciduum, but was below the level of detection in the myometrium (C, 200X).
Immunohistochemistry of dephosphorylated (i.e., active/nuclear) β-catenin was present on DOP 4.5 (E, 400X), but not DOP 7.5 (G, 400X). β-catenin
was not detected in control sections stained without primary antibody (D, F, H). Representative micrographs from n=3-5 independent
experiments.
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Because β-catenin expression increased dramatically in
uterine stromal cells during decidualization, we hypothe-
sized that this transcriptional co-activator functions to
facilitate stromal cell differentiation. Complete β-catenin
deficiency results in embryonic lethality [16]. Mice har-
boring the anti-Müllerian hormone type II receptor
(Amhr2) gene promoter-driven Cre recombinase gene
[17] were therefore used to conditionally delete Ctnnb1
when mated with mice harboring floxed Ctnnb1 alleles
[10]. Stromal and decidual cell-specific activity of Cre re-
combinase was first confirmed using the floxed EYFP re-
porter mouse. As shown in Figure 2A, EYFP fluorescence
was observed throughout the reproductive tract during
early pregnancy (DOP 6), as well as in artificially stimulated
deciduomal tissue of pseudopregnancy (DOPP 6) of double
transgenic Cre recombinase expressing EYFP reporter mice
(Amhr2
Cre/+;Rosa-EYFP). As anticipated, EYFP was only
observed in stromal cells of the endometrium from
Amhr2
Cre/+;Rosa-EYFP female mice on postnatal day 13,
Figure 2 Validating the use of the Amhr2
Cre transgenic mouse for studying gene function during uterine stromal cell decidualization.
Amhr2
Cre transgenic mice were crossed with double floxed yellow fluorescent protein (Cre/EYFP) transgenic mice. (A) At sexual maturity female
offspring were bred and implantation sites were observed grossly under fluorescent lighting on day of pregnancy 6 (DOP6, upper right and
lower left panels) or day of pseudopregnancy 6 (DOPP6, lower right panel). (B) Direct fluorescent microscopy was used to assess frozen
histological sections on postnatal day 13 (pnd13), DOP7 and DOPP7. Note that EYFP was present only in the stroma (ST) and myometrium (MYO)
on pnd13 and DOP7 and absent in the luminal (LE) and glandular (GE) epithelia (pnd13). Likewise, EYFP was not detected in certain cells at the
mesometrial pole that are presumably natural killer and endothelial cells (white arrows). EYFP was expressed at both the antimesometrial (anti)
and mesometrial (meso) poles on DOP7. No EYFP was observed in EYFP
flox/flox single transgenic mice (EYFP) that lack cre recombinase expression
(B, lower panels). All images taken at 400X magnification. DS, decidualized stroma; EM, embryo.
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mesometrium) and epithelial cells were devoid of EYFP
fluorescence (Figure 2B).
We next generated Amhr2
Cre/+;Ctnnb1
d/d double
transgenic conditionally null mice and used immuno-
fluorescence microscopy to confirm restricted deletion
of β-catenin from the stromal, but not epithelial com-
partment. Total β-catenin was observed in epithelia of
both Ctnnb1
flox/flox control (Figure 3A) and Amhr2
Cre/+;
Ctnnb1
d/d mutant (Figure 3B) uteri, as well as in the
sub-luminal stromal compartment of Ctnnb1
flox/flox uteri.
Uterine tissues from control and mutant female mice
maintained equitable potential to respond to female sex
steroids in that they express similar levels of classical sex
steroid hormone receptors based on immunohistochemical
detection of ESR1 (Figure 3E, F) and PGR (Figure 3G, H),
as well as mRNA expression of each receptor as deter-
mined by semi-quantitative RT-PCR (data not shown).
Amhr2
Cre/+;Ctnnb1
d/d female mice are infertile due in
part to incomplete development of the oviduct [18,19].
To study the impact of β-catenin deficiency within the
stromal compartment on uterine function, decidualiza-
tion was induced artificially in female mice bred to
vasectomized male mice on day of pseudopregnancy
(DOPP) 4. This approach circumvented the need for an
intact oviduct and embryo deposition into the uterus for
the initiation of decidualization. While Ctnnb1
flox/flox
control mice showed normal decidualization reaction 36–
72 h after induction, uteri from Amhr2
Cre/+;Ctnnb1
d/d
female mice could not be stimulated to undergo deciduali-
zation (Figure 4A). Histological analysis confirmed this
finding (Figure 4B-C). To rule out the possibility that uteri
from Amhr2
Cre/+;Ctnnb1
d/d mice fail to decidualize due to
insufficient endogenous ovarian steroid hormone synthe-
sis, ovariectomized Ctnnb1
flox/flox control and Amhr2
Cre/+;
Ctnnb1
d/d mice were exposed to exogenous steroids in a
regimen that mimicked early pregnancy to induce artificial
decidualization [20]. Steroid supplemented control mice
show normal decidualization reactions at 36–72 h based
on histological examination (Figure 4E), but uteri from
Amhr2
Cre/+;Ctnnb1
d/d mice were again incapable of
undergoing decidualization (Figure 4D). These findings in-
dicate that stromal β-catenin is essential for uterine
decidualization.
A role for stromal β-catenin in steroid hormone signaling
Decidualization requires exposure of the uterus first to
E2 followed by P4. Since decidualization failed in
Amhr2
Cre/+;Ctnnb1
d/d mice, we next studied whether the
loss of β-catenin interfered with steroid hormone signal-
ing in control and mutant female mice. Gross
(Figure 5A) and histological (Figure 5B) examination of
uteri exposed to a single injection of E2 (100 ng, 24 h)
revealed that uteri from both Ctnnb1
flox/flox control and
Amhr2
Cre/+; Ctnnb1
d/d mice become edematous, a nor-
mal physiological response to E2. A more subtle re-
sponse to E2 was observed in Amhr2
Cre/+;Ctnnb1
d/d
uteri, but this likely stems from reduced early postnatal
growth of uterine mesenchyme rather than from a lack
of an E2 signaling cascade. This can be seen when com-
paring uteri from Ctnnb1
flox/flox and Amhr2
Cre/+;
Ctnnb1
d/d mice exposed to vehicle (Figure 5B) and is
supported by an equal number of E2-induced epithelial
cell mitoses (i.e., phospho-histone H3 immunostaining)
in control and mutant uteri (Figure 5C) suggesting nor-
mal E2-induced epithelial cell proliferation. This experi-
ment was then repeated using the BrdU labeling (i.e.,
marker of proliferation) approach and it was again deter-
mined that β-catenin-deficiency within the stromal com-
partment did not compromise epithelial cell proliferation
G
E
H
F
AB
CD
Figure 3 Equitable steroid hormone receptor expression in
control and mutant uteri. Immunofluorescent detection of total β-
catenin in Ctnnb1
flox/flox control (A) and Amhr2
Cre/+; Ctnnb1
d/d mutant
(B) uteri (200X). Total β-catenin was not detected in sections where
primary antibody was omitted (C, D). Immunohistochemical
detection of ESR1 in control (E) and mutant uteri (F), as well as PGR
protein expression in control (G) and mutant (H) uteri. Representative
micrographs from n=3 independent experiments.
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were exposed to E2 and P4 in a regimen consistent with
early pregnancy to determine if stromal cell proliferation
was altered in the endometria of conditionally null Ctnnb1
female mice. As shown in Figure 5G-I, stromal β-catenin-
deficiency did not significantly reduce stromal cell prolifera-
tion in response to steroid hormones. Collectively, these
results suggest that the lack of β-catenin in endometrial
stroma does not materially affect steroid hormone-induced
cellular proliferation or stromal imbibition.
We next examined whether the failure of Amhr2
Cre/+;
Ctnnb1
d/d mice to undergo decidualization could be due
to disruption of other critical signaling pathways that
coordinate mesenchymal-to-epithelial communication.
Mechanical decidualization was performed on 4–5 week
old ovariectomized control and mutant mice for micro-
array analyses of P4-induced genes. Following treatment
with a hormone regimen consistent with early preg-
nancy, the mRNAs of many known targets of P4 signal-
ing during early pregnancy were disrupted in mutant
uteri. One pathway in particular, the Indian hedgehog
signaling pathway (Gli1, Ptch1, Ihh), was markedly
reduced in mutant uteri (Figure 6A-C). In contrast,
Muc1, a gene that is down-regulated at the time of
embryo attachment and is a P4 target gene, remained
elevated in mutant, but not control, uteri (Figure 6D).
Interestingly, histological evaluation of transverse uterine
sections 18 h after the final injection of combined E2
and P4 revealed that while control uteri showed the
expected simple columnar epithelium and general tissue
architecture (Figure 7A-B), uteri from 3/9 (33%)
Amhr2
Cre/+;Ctnnb1
d/d female mice displayed luminal
epithelial metaplasia containing cystic structures and
marked recruitment of leukocytes, particularly into the
luminal space (Figure 7C-D). This observation prompted
us to evaluate serial sections from control and mutant
uteri exposed to E2 for 24 h. Here, regions of bilaminar
stratification were observed within the luminal epithe-
lium in 66% (4/6) of the mutant uteri (Figure 7E). Con-
sistent with previous findings in which Ctnnb1 was
deleted using Pgr-cre [21], the posteriorization of the
uterus shown here suggests that stromal β-catenin is
necessary for maintenance of simple epithelial architec-
ture within the uterus in response to E2.
Discussion
Adult endometrial functions are temporally regulated by
sex steroid hormones that require interplay between the
epithelial and underlying stromal compartments. Ovar-
ian-derived E2 generated during each estrous/menstrual
cycle stimulates epithelial cell proliferation. The prolif-
erative epithelial response to E2 is largely an indirect
event that involves stromal release of epithelial mitogens
such as IGF-1 [22,23]. It was recently established
through conditional mutagenesis studies that stromal-
derived ESR1 is fundamental for directing epithelial cell
proliferation, while epithelial ESR1 is dispensable [24].
In turn, ovarian P4 completely abolishes E2-induced epi-
thelial cell proliferation in vivo [25]. Clinically, P4 is
applied prophylactically in some settings to treat estro-
gen-dependent endometrial cancer and to alleviate po-
tential complications during hormone replacement
therapies that can arise due to the unopposed actions of
estrogens. These fundamental actions of E2 and P4
A
BC
mutant control
E D
Figure 4 Conditional deletion of Ctnnb1 from the stromal
compartment results in failed uterine decidualization.
(A) Shown are whole uteri isolated from control (Ctnnb1
flox/flox) and
mutant (Amhr2
Cre/+;Ctnnb1
d/d) female mice. (B-E) Histological
transverse sections of uteri induced to undergo decidualization for
36 h. Uteri were obtained from intact control (C, E) or mutant (B, D)
female mice in which endogenous steroids and pseudopregnancy
primed uteri for the deciduogenic response (B, C), or from
ovariectomized female mice receiving an exogenous hormone
regimen consistent with that of early pregnancy [D, E; two days of
E2 (100 ng s.c. in 100 μl sesame oil), two days no treatment, three
days P4 (1 mg s.c. in 100 μl sesame oil) and one day E2+P 4]. Note
that while uteri from control mice show clear signs of
decidualization at 36 h post-induction (C, E), uteri from mutant mice
do not decidualize (B, D). Representative results from n=4-5
independent experiments.
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pharmacological studies where steroid hormone actions
are attenuated, as well as through the use of mutant
mice deficient in expression of ESR1 and PGR.
Amhr2
Cre/+;Ctnnb1
d/d mice are infertile, which engen-
ders two previously unappreciated points for consider-
ation. First, that deletion of Ctnnb1 from the stromal,
but not epithelial, compartment results in failed decidua-
lization, suggests that this transcriptional co-activator
mediates steroid hormone actions in the endometrium
that are critical for fertility. Further investigation is
needed to determine if β-catenin interacts in parallel
with PGR, forming a complex that in turn regulates
expression of genes in stromal tissue whose encoded
products contribute to decidualization. Precedence for
the convergence of β-catenin and steroid hormone sig-
naling pathways has been established in the uterus. Al-
ternatively, the PGR and β-catenin signaling pathways
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Figure 5 Ctnnb1
flox/flox control and Amhr2
Cre/+;Ctnnb1
d/d mutant uteri responsd similarly to steroid treatments in terms of epithelial and
stromal cell proliferation. Representative images of whole uteri (A) or histological sections (B) from control or mutant female mice treated with
vehicle (veh or v) or estradiol (E2, 100 ng, 24 h). (C) Based on immunohistochemical detection of the mitosis marker phospho-histone H3, no
difference was observed in the percentage of epithelial mitotic cells between control and mutant mice exposed to vehicle or E2. When
employing the BrdU labeling method, no statistical difference was observed in proliferation in control (D, G) and mutant (E, H) luminal epithelia
in response to E2 (D-F; 50 ng, 24 h) or stromal cells in response to steroid hormones given in a regimen consistent with early pregnancy [G-I;
two days of E2 (100 ng s.c. in 100 μl sesame oil), two days no treatment, three days P4 (1 mg s.c. in 100 μl sesame oil) and one day E2+P 4]). Data
represent the mean ± SEM from n=3-8 independent experiments where * denotes p<0.05.
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another pathway, such as WNTs that in turn utilize β-
catenin function. This scenario is supported by recent
findings where WNT4 was shown to be a key regulator
of normal postnatal uterine development and progester-
one signaling during embryo implantation and deciduali-
zation [26]. Additional evidence for a PGR-β-catenin
interaction comes from in vitro decidualization studies
using human stromal cells where PGR expression was
shown to be essential for nuclear translocation of
β-catenin [27].
The second point for consideration is that stromal
β-catenin is necessary for transcriptional regulation of
both stromal and epithelial factors that are important for
initiating decidualization and embryo attachment. Stro-
mal β-catenin-deficiency results in failed up-regulation
of Ihh in the epithelium, as well as Ptch1 and Gli1 in the
stroma suggesting that stromal P4 signaling mediates
events not only in the stromal compartment, but also in
the overlying epithelium. It is concluded from this inves-
tigation that stromal β-catenin is a component of the
signaling conduit through which P4 coordinates events
in the overlying epithelium. Recent tissue recombination
studies involving the use of wild type and Pgr-null
stroma and/or epithelia support this concept [28]. Here,
Simon et al. established that neonatal tissue recombinants
containing wild type epithelium and PGR-deficient stroma
were unable to show elevated levels if Ihh in the epithe-
lium in response to P4 treatment [28].
Some studies have suggested direct inhibitory actions
of P4 on E2-induced epithelial cell proliferation. During
the time of embryo implantation on day 4 of pregnancy
in mice the epithelium does not express PGR despite ob-
servation of clear progestational response on the epithe-
lium [29,30]. How then does P4 signal in the epithelium
in the absence of PGRs? The “progestamedin hypothesis”
suggests that P4-induced paracrine factors secreted from
the stromal compartment indirectly regulate P4 actions
on the epithelium [30]. It was recently established that
E2-induced epithelial proliferation is suppressed by P4
actions in the stromal compartment involving a HAND2-
dependent mechanism [31]. Progesterone induces the
transcriptional inhibitor HAND2, which in turn sup-
presses specific members of the fibroblast growth factors
family in the stromal compartment [31]. Our study places
β-catenin squarely in the middle of P4-dependent mesen-
chymal-to-epithelial signaling during the initiation of ma-
ternal:embryo interaction.
A number of signaling factors and down-stream tran-
scription factors have been identified through mutant
mouse studies as critical components coordinating
decidualization. Some of these include IHH, WNT4,
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Figure 6 Real time RT-PCR demonstrating differential mRNA expression of genes critical for embryo implantation. Control and mutant
uteri were obtained from female mice treated with a steroid hormone regimen consistent with early pregnancy [two days of E2 (100 ng s.c. in
100 μl sesame oil), two days no treatment, three days P4 (1 mg s.c. in 100 μl sesame oil) and one day E2+P 4]). Shown are real time RT-PCR results
for Gli1 (A), Ptch1 (B), Ihh (C) and Muc1 (D). Data represent mean+SEM of n=4 independent experiments.
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reviewed in [32]. Indian hedgehog localizes to the epi-
thelium in response to P4 at the time of embryo implant-
ation, and tissue restricted deletion of the gene using the
PgrR-Cre mouse model results in failed decidualization
[33-35]. From our study it is clear that transcription of
members of the IHH pathway is reduced in Amhr2
Cre/+;
Ctnnb1
d/d uteri in response to steroid hormones; how-
ever, additional functional studies are necessary to deter-
mine exactly how β-catenin is linked to the IHH
signaling pathway.
Uteri from Amhr2
Cre/+;Ctnnb1
d/d mice are smaller in
size than control uteri, which could confound the inter-
pretation of these results. However, four lines of
evidence suggest that the failure of Amhr2
Cre/+;Ctnnb1
d/d
uteri to decidualize stems from disruption of steroid hor-
mone receptor signaling rather than from altered prenatal
or early postnatal uterine development. First, expression
studies reveal that uteri from Amhr2
Cre/+;Ctnnb1
d/d mice
have the potential to respond normally to E2 and P4 in that
uterine mRNA and protein levels of ESR1 and PGR do
not differ between control and mutant female mice. Sec-
ond, uteri from control and mutant female mice display a
normal response to E2, at least in terms of epithelial prolif-
eration and stromal imbibition. Since the stromal com-
partment mediates the proliferative response in the
epithelium, our findings indicate that the uterine stromal
compartment of Amhr2
Cre/+;Ctnnb1
d/d mice is fully
C
A
D
B
E
Figure 7 Stromal β-catenin deficiency results in development of luminal metaplastic lesions in Amhr2
Cre/+;Ctnnb1
d/d mutant uteri
following steroid hormone treatment. Hematoxylin and eosin stained sections from Ctnnb1
flox/flox control (A, B) and Amhr2
Cre/+;Ctnnb1
d/d
mutant (C, D) uteri following treatment of ovariectomized female mice with a steroid hormone regimen consistent with early pregnancy [two
days of E2 (100 ng s.c. in 100 μl sesame oil), two days no treatment, three days P4 (1 mg s.c. in 100 μl sesame oil) and one day E2+P 4].
(E) Regions of bilaminar stratification (black arrows) were observed within the luminal epithelium in 66% (4/6) of the mutant uteri following E2
(100 ng, 24 h) treatment. Representative images from n=6-9 independent experiments.
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lium. Third, the actions of P4 are not completely ablated
in the uteri of Amhr2
Cre/+;Ctnnb1
d/d mice, since several
genes previously shown to be targets of P4 action show
the expected pattern of expression. For instance, Hmga2
(high mobility group AT-hook 2), Cdkl1 (cyclin-dependent
kinase-like 1), and Ldb2 (LIM domain binding 2) were
shown to be down-regulated by P4 treatment in vivo [36].
Based on our microarray analysis each of these genes was
down-regulated similarly in control Ctnnb1
flox/flox and mu-
tant Amhr2
Cre/+;Ctnnb1
d/d uteri in vivo (data not shown).
Conversely, S100a6 (calcyclin), Irg-1 (immune responsive
gene-1) and Fst (follistatin), three genes shown to be up-
regulated by P4 [37], were equitably up-regulated in
Ctnnb1
flox/flox and Amhr2
Cre/+;Ctnnb1
d/d uteri (data not
shown). Fourth, indifferent stromal cell proliferation was
observed in response to a hormone regimen consistent
with early pregnancy. This suggests that the proliferative
stromal cell response to P4 is not dependent upon β-catenin.
In sum, these findings indicate that β-catenin deficiency in
the stromal compartment of Amhr2
Cre/+;Ctnnb1
d/d uteri
results in aberrant gene expression of a specific cassette of
P4-dependent genes, several of which belong to the IHH
signaling cascade, but that other P4 responses are normal.
Two functional studies were previously published on
β-catenin in the uterus. In the first, β-catenin activity
was indirectly assessed through the use of Tcf/Lef-LacZ
transgenic mice [38]. Here, β-galactosidase activity was
used to identify coupling of β-catenin with the TCF/LEF
transcriptional complex in situ. Based on this model, β-
catenin activity was observed in the luminal epithelium
and circular smooth muscle, an event that required the
presence of an embryo. It was concluded that β-catenin
was no longer active by late DOP5. However, β-catenin
activity was defined by its ability to activate the Tcf/Lef-
LacZ transgene, and β-catenin function was not
addressed using deletional analysis (e.g., gene knock-
down or mutant mice deficient in β-catenin). Addition-
ally, while we and others [14] have since demonstrated
the presence of active (i.e., dephosphorylated and
nuclear) β-catenin in decidualizing stromal cells,
Mohamed et al. were unable to detect transcriptional ac-
tivity for the TCF/LEF complex in the stromal compart-
ment, suggesting β-catenin may regulate gene expression
within the stromal compartment by a TCF/LEF-inde-
pendent mechanism.
More recently, Jeong et al. used the Pgr-Cre transgenic
mouse line to delete β-catenin from PGR-expressing tis-
sues, including all compartments of the uterus [21].
Using this model system, β-catenin deficiency in the en-
tire uterus resulted in pleiotropic effects leading to infer-
tility, most likely because of the inability of stromal cells
to terminally differentiate and E2-induced morphological
defects. The design, and therefore the conclusion, of our
study differ to some extent from this previous report.
First, while uteri from Amhr2
Cre/+;Ctnnb1
d/d female mice
lack expression of β-catenin in the myometrial and stromal
compartments, as with the Pgr-Cre model, expression of β-
catenin was retained in luminal and glandular epithelia
using the Amhr2
Cre mouse line. Second, deletion of β-cate-
nin in all compartments of the uterus resulted in metaplas-
tic formation of the luminal epithelium in the intact mouse
[21]. Analysis of the ovaries indicated that ovarian function
was preserved. Jeong et al., concluded that β-catenin defi-
ciency in the epithelium was the source of the metaplastic
phenotype. This conclusion is well justified in that muta-
tions in the human Ctnnb1 gene are commonly associated
with endometrial hyperplasia. Although our data does not
rule out control of epithelial metaplasia by epithelial β-
catenin, they indicate that, since Amhr2
Cre/+;Ctnnb1
d/d
mutant uteri also develop metaplasia, albeit with reduced
severity and incidence, the lack of β-catenin in stroma
alone can dictate formation of epithelial metaplasia. As
with β-catenin, deletion of APC, a component of the β-
catenin signaling pathway, from the uterine stromal com-
partment results in a more severe phenotype where endo-
metrial hyperplasia and carcinogenesis are observed [39].
Conclusion
Because β-catenin is connected to a multitude of cellular
processes, we investigated the functional requirement of
β-catenin in the stromal compartment of the endomet-
rium for decidualization and responsiveness to steroid
hormones. Our findings indicate that β-catenin is essen-
tial for early events in the terminal differentiation of uter-
ine stromal cells. While it is well established that the
stromal compartment indirectly coordinates epithelial cell
proliferation through production of paracrine growth fac-
tors, deletion of stromal β-catenin did not alter E2-stimu-
lated epithelial cell mitosis. Our study also provides
evidence that the stromal compartment, through activa-
tion of β-catenin, mediates as least some of the actions of
P4 on the epithelium. It will now be important to delin-
eate upstream signaling pathways that activate stromal β-
catenin and to identify β-catenin target genes that are
necessary for disseminating steroid hormone actions on
the epithelium, in addition to its role in decidualization
within the stromal compartment.
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